MyFinsight
Home
Blog
About
NANOVIRICIDES, INC. (NNVC)
NANOVIRICIDES, INC. (NNVC)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$1,930,582
Unit: Dollar
Positive Cash Flow Breakdown
Depreciation
Common stock issued as compensat...
Preferred stock issued as compen...
Others
Negative Cash Flow Breakdown
Net loss
Accounts payable
Accounts payable - related party
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-1,989,333
-2,220,719
-1,785,058
-9,466,966
Preferred stock issued as compensation
14,896
11,584
11,632
60,722
Common stock issued as compensation and for services
56,231
185,100
38,250
162,625
Warrants granted to scientific advisory board
88
123
135
679
Depreciation
127,566
131,016
130,752
735,536
Amortization
2,068
2,067
2,068
8,269
Prepaid expenses
18,671
19,130
14,709
-60,596
Other assets
-349
-355
-358
-12,117
Accounts payable
-83,442
-183,480
-57,301
82,824
Accounts payable - related party
-24,542
28,089
79,687
101,417
Accrued expenses
-15,792
15,338
331
-236,498
Net cash used in operating activities
-1,930,582
-2,049,657
-1,593,855
-8,478,679
Purchase of property and equipment
0
-1
84,317
56,964
Net cash used in investing activities
0
1
-84,317
-56,964
Net proceeds from sale of common stock, net of issuance costs
0
1,909,121
-
-
Net proceeds from sale of common stock
-
-
1,245,319
5,296,429
Net proceeds from sale of common stock and common stock warrants, net of issuance costs
-6,742
5,410,723
-
-
Net cash provided by financing activities
-6,742
6,074,525
1,245,319
5,296,429
Net change in cash and cash equivalents
-1,937,324
4,024,869
-432,853
-3,239,214
Cash and cash equivalents at beginning of period
1,125,711
1,125,711
1,558,564
4,797,778
Cash and cash equivalents at end of period
3,213,256
5,150,580
1,125,711
1,558,564
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net change in cash
and cash...
-$1,937,324
Depreciation
$127,566
Common stock issued as
compensation and for services
$56,231
Preferred stock issued as
compensation
$14,896
Amortization
$2,068
Other assets
-$349
Warrants granted to
scientific advisory board
$88
Net cash used in
operating activities
-$1,930,582
Net cash provided by
financing activities
-$6,742
Canceled cashflow
$201,198
Net loss
-$1,989,333
Net proceeds from
sale of common stock...
-$6,742
Accounts payable
-$83,442
Accounts payable -
related party
-$24,542
Prepaid expenses
$18,671
Accrued expenses
-$15,792
Buy us a coffee